Rezolute Inc (RZLT)

Rezolute Inc (RZLT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $396M; returns 1 day -0.1%, 1 week +7.7%, 1 year -57.3%.

Rezolute, Inc. is a late-stage biopharmaceutical company focused on developing therapies for rare metabolic diseases, particularly those associated with chronic glucose imbalance. Their lead product candidate was ersodetug, a human monoclonal antibody targeting hyperinsulinism (HI), a condition causing life-threatening hypoglycemia.

Groups RZLT belongs to

• Biotechnology
• Biopharmaceutical
• Rare Diseases
• Clinical Stage
• Clinical Stage Biopharma
• Metabolic Disorders
• Monoclonal Antibodies
• Healthcare
• Unmet Medical Needs
• Life Sciences

RZLT financial model: income statement, cash flow and balance sheet